Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 2 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar bIlluminati (30.74) Submitted: 8/20/2012 2:33:16 PM : Underperform Start Price: $1.62 ASTM Score: +8.21

New - no profits - stock weakness.

Featured Broker Partners


Advertisement